Supporting Meal Management in Type 1 Diabetes (NCT05671679) | Clinical Trial Compass
CompletedNot Applicable
Supporting Meal Management in Type 1 Diabetes
Switzerland44 participantsStarted 2023-03-27
Plain-language summary
Carbohydrate count marks the cornerstone of Type 1 Diabetes management. Eventhough it is a crucial task, it is burdensome and prone to error. Therefore, the investigators want to explore the effect that SNAQ, a food analyser app would have in glycaemic control by facilitating the task of carbohydrate estimation.
Who can participate
Age range
18 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Written informed consent
* Adults (aged 18 years or older)
* Type 1 diabetes (as defined by World Health Organization (WHO) for at least 12 month)
* Current use of a commercial hybrid closed-loop system
* HbA1c≤12% (measured within the past 3 months)
* Willing to use the SNAQ app on a daily basis for over 3 weeks
* The participant is willing to follow study specific instructions and share their treatment data with the study team
Exclusion Criteria:
* Any physical or psychological disease or condition likely to interfere with the normal conduct of the study and interpretation of the study results
* Previous use of SNAQ app for more than 5 days within the past 3 months
* Self-reported pregnancy, planed pregnancy within next 3 months or breast-feeding
* Severe visual impairment
* Severe hearing impairment
* Lack of reliable telephone facility for contact
* Concomitant participation in another trial that interferes with the normal conduct of the study and interpretation of the study results
* Participant not proficient in German
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial focused on helping people with Type 1 Diabetes manage meals — can you explain what 'time in range' means for my glucose sensor readings, and how improving it might matter for my day-to-day health?
2Since this study is already completed, would you be able to share or look up what the results showed about whether the meal management support actually helped people spend more time in their target glucose range?
3The trial measured sensor glucose levels, so it seems like it required participants to use a continuous glucose monitor — if I'm not currently using one, is that something worth considering for my own management, separate from this trial?
4Given that this trial is finished and focused on meal management strategies, are there any findings or approaches from studies like this one that you'd recommend I try incorporating into my current diabetes care plan?
5Before looking at any research like this, I want to make sure I understand my options — is there a standard meal-planning or diabetes education program you'd suggest I explore first, and how would something like this trial's approach compare to what's already available to me?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Percentage of time with sensor glucose in the target range
Timeframe: 3-week intervention period (Day 1 to Day 21)